2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%

There's a lot of hope for these stocks, but there's also a fair amount of risk. Viking Therapeutics: 99% upside That optimism stems from the hopes analysts and investors have for VK2735, a glucagon-like peptide 1 (GLP1) treatment that has been demonstrating encouraging results in clinical trials. The potential for the drug to take market share in a $100 billion anti-obesity market has made Viking an attractive speculative investment with a lot of potential upside. If one or both of those treatments obtain a ...